Colorectal Cancer Clinical Trial
Official title:
Exposure to Virtual Reality as Psychosocial Intervention in Colorectal Cancer Surgery in Hospital Clinic of Barcelona, Spain
A prospective controlled randomized interventional study comparing the effects of the
preoperative exposure to a virtual reality software versus not exposure in 126 patients with
colorectal cancer. Patients will be divided in two randomized groups, each of them of 63
patients. The hypothesis of the study is that gradual exposure to the hospital environment
using a virtual reality software is effective to reduce preoperative anxiety.
The main variable is the level of anxiety in patients undergoing colorectal cancer surgery.
It will be measured using State-Trait Anxiety Inventory Scale (STAI-S) and the Hospital
Anxiety and Depression Scale (HADS).
Colorectal cancer is the third most frequent neoplasia diagnosed worldwide, and in Spain it
is the first in incidence and prevalence, accounting for 15% of all neoplasias according to
World Health Organization (WHO).
The incidence of preoperative anxiety in patients undergoing elective surgery is high (60% -
76%). There are many causes for this: anticipation of postoperative pain, loss of
independence, separation from the family, fear to the surgical procedure or to severe
complications or even death. The incidence of preoperative anxiety varies according to age,
sex, educational leve, previous exposure to surgical interventions and the expected impact of
the surgical procedure in global quality of life.
Patients with anxiety require higher dosis of induction anesthesia, longer hospital stay, and
a higher rate of perioperative complications due to a release of catecholamines, increase on
the oxidative demands, causing tachycardia, arrhythmia, high blood pressure, etc.
Gradual exposition is considered an effective way of reducing anxiety. It has been
demonstrated that anxiety is decreased in patients with history of surgical interventions,
and thus the experience is experimented as an adaptive process. Virtual reality gives the
opportunity to experience each of the steps of the hospital stay in a realistic environment.
The hypothesis of this study is that gradual exposure to the hospital environment using
virtual reality is an effective tool to reduce preoperative anxiety in patients undergoing
colorectal cancer surgery.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |